Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18476657> ?p ?o }
Showing triples 1 to 48 of
48
with 100 triples per page.
- Q18476657 subject Q7214969.
- Q18476657 subject Q8460853.
- Q18476657 subject Q8492054.
- Q18476657 subject Q8567712.
- Q18476657 abstract "Emtricitabine/rilpivirine/tenofovir (trade names Complera, Eviplera) is a fixed dose combination of antiretroviral drugs for the treatment of HIV. The drug was co-developed by Gilead Sciences and Johnson & Johnson's Tibotec division and was approved by the Food and Drug Administration in August 2011, and by the European Medicines Agency in November 2011, for patients who have not previously been treated for HIV. It is available as a once-a-day single tablet.In Europe it is commercialized as Eviplera and in the US as Complera.".
- Q18476657 wikiPageWikiLink Q1142055.
- Q18476657 wikiPageWikiLink Q130146.
- Q18476657 wikiPageWikiLink Q133244.
- Q18476657 wikiPageWikiLink Q1362864.
- Q18476657 wikiPageWikiLink Q1365091.
- Q18476657 wikiPageWikiLink Q1500373.
- Q18476657 wikiPageWikiLink Q15787.
- Q18476657 wikiPageWikiLink Q158289.
- Q18476657 wikiPageWikiLink Q176301.
- Q18476657 wikiPageWikiLink Q204711.
- Q18476657 wikiPageWikiLink Q2528140.
- Q18476657 wikiPageWikiLink Q254296.
- Q18476657 wikiPageWikiLink Q286846.
- Q18476657 wikiPageWikiLink Q28734.
- Q18476657 wikiPageWikiLink Q333718.
- Q18476657 wikiPageWikiLink Q3515.
- Q18476657 wikiPageWikiLink Q3935297.
- Q18476657 wikiPageWikiLink Q407241.
- Q18476657 wikiPageWikiLink Q410400.
- Q18476657 wikiPageWikiLink Q410412.
- Q18476657 wikiPageWikiLink Q421559.
- Q18476657 wikiPageWikiLink Q422210.
- Q18476657 wikiPageWikiLink Q422252.
- Q18476657 wikiPageWikiLink Q422652.
- Q18476657 wikiPageWikiLink Q476921.
- Q18476657 wikiPageWikiLink Q503629.
- Q18476657 wikiPageWikiLink Q5456317.
- Q18476657 wikiPageWikiLink Q553223.
- Q18476657 wikiPageWikiLink Q663596.
- Q18476657 wikiPageWikiLink Q6844.
- Q18476657 wikiPageWikiLink Q7214969.
- Q18476657 wikiPageWikiLink Q7632279.
- Q18476657 wikiPageWikiLink Q8460853.
- Q18476657 wikiPageWikiLink Q8492054.
- Q18476657 wikiPageWikiLink Q8567712.
- Q18476657 wikiPageWikiLink Q992172.
- Q18476657 type ChemicalSubstance.
- Q18476657 type Drug.
- Q18476657 type ChemicalObject.
- Q18476657 type Thing.
- Q18476657 type Q8386.
- Q18476657 comment "Emtricitabine/rilpivirine/tenofovir (trade names Complera, Eviplera) is a fixed dose combination of antiretroviral drugs for the treatment of HIV. The drug was co-developed by Gilead Sciences and Johnson & Johnson's Tibotec division and was approved by the Food and Drug Administration in August 2011, and by the European Medicines Agency in November 2011, for patients who have not previously been treated for HIV.".
- Q18476657 label "Emtricitabine/rilpivirine/tenofovir".